Since the beginning of the coronavirus disease-2019 (COVID-19) pandemic, a compelling evidence of the association between this infection and an increased risk of venous thromboembolism has drawn the attention of scientists and clinicians, and several studies have been carried out and published on this association [1]. A meta-analysis on the incidence of pulmonary embolism (PE) in patients with COVID-19 appears in this issue of the European Journal of Internal Medicine [2]. This meta-analysis, which includes data until August 1, 2020, encompasses 22 studies for a total of 7178 patients and reports an average rate of PE of 14.7% and 23.4% in patients admitted to general wards or intensive care units, respectively.
